• Regeneron Pharmaceuticals EPS for the quarter ending June 30, 2024 was $12.41, a 46% increase year-over-year.
• Regeneron Pharmaceuticals 2023 annual EPS was $34.77, a 9.03% decline from 2022.
• Regeneron Pharmaceuticals 2022 annual EPS was $38.22, a 46.89% decline from 2021.
• Regeneron Pharmaceuticals 2021 annual EPS was $71.97, a 135.81% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.